(Q43974455)

28 November 2017

title

Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome (English)

1 reference

28 November 2017

Benjamin D L Li

1

1 reference

28 November 2017

Jeffrey S Gruner

2

1 reference

28 November 2017

Fleurette Abreo

3

1 reference

28 November 2017

Lester W Johnson

4

1 reference

28 November 2017

Herbert Yu

5

1 reference

28 November 2017

Soheir Nawas

6

1 reference

28 November 2017

John C McDonald

7

1 reference

28 November 2017

Arrigo DeBenedetti

8

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

235

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

732-8; discussion 738-9

1 reference

Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F.

28 November 2017

cites work

1 reference

12 December 2020

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

12 December 2020

Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts.

1 reference

12 December 2020

Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E

1 reference

12 December 2020

Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation.

1 reference

12 December 2020

The proto-oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas

1 reference

12 December 2020

Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation.

1 reference

12 December 2020

Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis

1 reference

12 December 2020

Overexpression of the proto-oncogene/translation factor 4E in breast-carcinoma cell lines

1 reference

12 December 2020

Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer

1 reference

12 December 2020

Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma

1 reference

12 December 2020

Pathologic prognostic factors for patients with breast carcinoma. Which factors are important

1 reference

12 December 2020

Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival

1 reference

12 December 2020

Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression

1 reference

12 December 2020

Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer

1 reference

12 December 2020

eIF4E expression in tumors: its possible role in progression of malignancies

1 reference

12 December 2020

Significance of axillary lymph node metastasis in primary breast cancer

1 reference

12 December 2020

Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer

1 reference

12 December 2020

The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients

1 reference

12 December 2020

A translationally regulated Tousled kinase phosphorylates histone H3 and confers radioresistance when overexpressed

1 reference

12 December 2020

Predicting axillary nodal positivity in 2282 patients with breast carcinoma

1 reference

12 December 2020

Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up

1 reference

12 December 2020

Why data bases should not replace randomized clinical trials

1 reference

12 December 2020

The role of observational studies in the evaluation of therapy

1 reference

12 December 2020

Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology

1 reference

12 December 2020

Mechanism of action and regulation of protein synthesis initiation factor 4E: effects on mRNA discrimination, cellular growth rate, and oncogenesis.

1 reference

12 December 2020

10.1097/00000658-200205000-00016

Identifiers

DOI

1 reference

28 November 2017

1 reference